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Abstract: Bone injuries that arise from trauma, cancer treatment, or infection are a major and
growing global challenge. An increasingly ageing population plays a key role in this, since a
growing number of fractures are due to diseases such as osteoporosis, which place a burden
on healthcare systems. Current reparative strategies do not sufficiently consider cell-substrate
interactions that are found in healthy tissues; therefore, the need for more complex models is clear.
The creation of in vitro defined 3D microenvironments is an emerging topographically-orientated
approach that provides opportunities to apply knowledge of cell migration and differentiation
mechanisms to the creation of new cell substrates. Moreover, introducing biofunctional agents within
in vitro models for bone regeneration has allowed, to a certain degree, the control of cell fate towards
osteogenic pathways. In this research, we applied three methods for functionalizing spatially-confined
electrospun artificial microenvironments that presented relevant components of the native bone
stem cell niche. The biological and osteogenic behaviors of mesenchymal stromal cells (MSCs)
were investigated on electrospun micro-fabricated scaffolds functionalized with extracellular matrix
(ECM) proteins (collagen I), glycosaminoglycans (heparin), and ceramic-based materials (bioglass).
Collagen, heparin, and bioglass (BG) were successfully included in the models without modifying
the fibrous structures offered by the polycaprolactone (PCL) scaffolds. Mesenchymal stromal cells
(MSCs) were successfully seeded in all the biofunctional scaffolds and they showed an increase in
alkaline phosphatase production when exposed to PCL/BG composites. This research demonstrates
the feasibility of manufacturing smart and hierarchical artificial microenvironments for studying
stem cell behavior and ultimately the potential of incorporating these artificial microenvironments
into multifunctional membranes for bone tissue regeneration
Keywords: artificial microenvironment; ECM proteins; bioglass; electrospun membrane;
bone regeneration
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1. Introduction
Over the past decade, bone-related injuries have been identified as a major global problem
that have increasingly affected people’s wellbeing [1]. The number of bone fractures in northern
hemisphere countries is increasing and is currently predicted to rise to 4.5 million cases by 2025 [2].
Aging populations and related illnesses including osteoporosis are closely related to this fact. Thus,
the treatment of bone-based musculoskeletal injuries represents an increasing wellbeing and economic
burden for national healthcare systems. Although healthy bone tissue has inherent self-healing
properties, large or compromised bone defects (including non-union and infection) remain a major
clinical challenge.
The gold standard treatment for bone repair is based on the use of autografts and allografts,
which are subjected to associated problems, including limited availability, morbidity, and risk of infection
amongst other issues. Orthobiologic therapies have also been explored for promoting bone healing
and include the use of cells, genes, and proteins [3]. Despite their promising performance, they are
overpriced (in part due to significant regulatory barriers) and have associated risks. Hydroxyapatite
(HA) and bioactive glasses (BG) have been broadly explored and included within artificial constructs
as inorganic components to encourage intrinsic osteoconductive properties, mimicking the mineral
part of the native bone [4,5]. The fields of bone tissue engineering and regenerative medicine have
definitely made successful progress in the design of smart biomaterials and scaffolds for bone healing
in the past decades but, despite being innovative and relatively effective, these approaches do not
tackle in a single step the challenges faced by the bone tissue engineering community. In essence,
current models do not recreate microenvironments in which stem cells develop and coexist in vivo.
Stem cells present unique self-renewal features and are known to be fundamental for repairing and
maintaining tissues throughout life; their behavior is complex and regulated both by intrinsic cellular
programs and extrinsic signals dictated by the surrounding environment (niche). Stem cell niches
can be described as intricate microenvironments that play an important role in stem cell renewal
and differentiation. The existence of stem cell niche as a physically defined environment was first
proposed by Schofield in 1978 [6]. The intricate anatomy of the stem cell microenvironment as well as
the complicated biochemical cues involved in its regulation make the location and identification of
stem cell niches a difficult task. Stem cell niches have been identified in many different tissues such as
the bulge area of hair follicles [7] and the crypt base in the intestine [8]. Likewise, corneal stem cells
have been located in the limbal area of the eye [9,10] and neural stem cells are believed to reside in
regions such as the subventricular zone and the hilus of the dentate gyrus [11]. Current stem cell niche
paradigms suggest that a successful niche environment depends on a combination of three related
elements: (1) a well-defined 3D structure, which provides some physical protection; (2) the presence of
cells with stem cell capability, surrounded by specific extracellular matrix (ECM) components; and (3)
the presence of stromal cells with the ability of interacting with the other cells in the niche through
distinct soluble factors [12–14].
Mimicking the behavior of the stem cell niche is a challenging task but currently developed
strategies can mimic “certain aspects of the stem cell niche” via the control of a small number of variables
and the design of “artificial stem cell niches”. These studies have reported successful results including
the following findings: (i) the study of primary rat mesenchymal stem cell (rMSCs) behavior [15,16]
and the glial origin of MSCs [17]; (ii) the creation of neural microfabricated devices [18]; (iii) the
development of artificial niche models for the study of limbal stem cell behavior [19–22]; and (iv) the
study of embryonic and hematopoietic stem cell responses [23–25]. Mimicking the stem cell niche
becomes even more challenging when it specifically targets “bones” since at least two different niches
have been identified in bone marrow (osteoblastic and vascular niche respectively) [26].
In the literature, it is possible to find different approaches to mimic the bone stem cell niche by
stimulating osteogenesis and consequently improving bone repair. Minardi et al. observed that human
MSCs osteogenic differentiation was stimulated when cultured on nanocrystalline magnesium-doped
HA/collagen type I composite scaffolds and observed that such scaffolds stimulated bone formation in
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a rabbit ectopic mode [27]. A different model was presented by Danti et al. by culturing multistage
osteogenic hMSCs on biodegradable Poly L-lactic acid (PLLA)/gelatine spongy scaffolds. A cell
population with different osteogenic differentiation stages was obtained by culturing undifferentiated
cells on the scaffolds with osteogenic medium and by periodically seeding new undifferentiated MSCs
(cell shots) into the same scaffold. This method allowed for the development of a stem cell niche with
graded osteogenicity characteristics which presented similarities with the bone MSCs populations in
in vivo niches [28].
More recently, Muerza-Cascante et al. developed melt electrospun polycaprolactone (PCL)
calcium-phosphate coated and NaOH-etched scaffolds for bone repair. These scaffolds were seeded
with primary human osteoblasts and placenta-derived human MSCs in osteogenic and non-osteogenic
conditions in order to develop an endosteal-like tissue. As a result, endosteal ECM deposition was
enhanced in osteoblasts in osteogenic conditions but not in MSCs, independently of the scaffold surface
treatment [29]. Further, a study by Tang et al. focused on mimicking bone porous architecture and
biological cues to be used in the regeneration of large bone defects. To achieve this, a macro/micro/nano
scaffold with “sized matched entrapped” bone morphogenetic protein-2 (BMP-2) was developed.
Providing osteoconductivity and osteoinductivity in different scales, the porous scaffolds managed to
improve bone regeneration in vivo by stimulating ectopic bone formation in mice and bone formation
in rabbits [30].
Although, as cited above, there have been attempts to mimic the complexity of the bone marrow
stem cell niche using intricate 3D culture approaches [31], the reality is that the development of a
functional bone stem cell microenvironment still remains a big challenge.
This project proposes the use of topographical and mechano-biological cues as tools for creating
niche-like structures for studying bone regeneration. Although using topography by itself for
directing cell behavior has successfully been reported [15,25], the incorporation of extracellular matrix
components would allow us to create a more relevant hierarchical construct that mimics closer the
mechano-biology of the native substrate. In this sense, we chose to use collagen I (Figure 1) as an
example of ECM structural protein, which has also been identified in most tissues including bone [32].
We also explored the incorporation glycosaminoglycans (GAGs), specifically heparin (Figure 1),
since sulphated glycosaminoglycans have demonstrated to undertake key roles in driving stem cell
differentiation and have been identified both in the surfaces of animal cells and within the ECM [33].
 
 
Figure 1. General schematic of a stem cell niche environment showing key characteristics, cell type
locations, and highlighting (in green) the specific components we aimed to investigate in this work
(manufacture of a physical and discrete space and biofunctionalization with extracellular matrix (ECM)
and mineral components (Bioglass, BG)).
The inorganic bone phase should also be considered when developing new models for bone
healing (Figure 1) and it has been widely reported that the use of mineral-doped scaffolds shows
great promise in bone tissue regeneration [34]; for example, the addition of HA in both natural and
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synthetic-based materials has resulted in an increase of osteogenic differentiation [35–37]. The use of
BG as a ceramic-based phase for driving cell fate has also been reported [38,39]. The work we present
here focuses on the use of this approach for scaffold biofunctionalization (specifically using BG) and
relies on the use of innovative additive manufacturing techniques (AM) and conventional fabrication
techniques (electrospinning).
The aim of this research was to design and manufacture a complex hierarchical membrane
equipped with key niche biofunctional microenvironments that could direct cell behavior by providing
a topographical and mechano-biological relevant native-like substrate. These new membranes set the
basis for the future development of complex and multifunctional medical devices that can ultimately
have the ability to control stem cell fate and function for aiding in bone healing.
2. Materials and Methods
2.1. Manufacture of Electrospun Membranes
Electrospinning solutions containing 10 wt % of Poly(ε-caprolactone) (PCL; average molecular
weight = 80,000; Sigma-Aldrich®, Sheffield, UK) were prepared using dichloromethane (DCM;
Fisher Scientific®, Sheffield, UK) and N,N-dimethylformamide (DMF; Fisher Scientific®, Sheffield, UK).
The solutions were stirred overnight until homogenous. The fabrication of the electrospun mats was
performed using a custom-made electrospinning machine. A Kd scientific pump was used to eject the
polymer solution out of a 1 mL plastic syringe (Becton Dickinson, Sheffield, UK) through a 20-gauge
blunt metallic needle. The needle was connected to an external Alpha IV Brandenburg power source,
supplying an electric current. The polymer solution was delivered at a constant rate flow (3 mL/h) to a
metallic collector that was connected to a voltage power supply. Upon applying a voltage of 17 kV, a fluid
jet was ejected from the syringe towards the collector that was placed at a distance of 21 cm. The solvent
evaporated and charged polymer fibers were deposited on the collector in the form of non-woven
fibers. Scaffolds with and without microfeatures were manufactured under the same electrospinning
conditions. When plain scaffolds (without included topography) were fabricated, the fibers were
collected directly on a foil covering the metallic collector. Scaffolds with microfeatures (mats with
incorporated 3D-topographical cues) were fabricated using stainless additive-manufacturing-designed
metallic templates as previously reported [15] (see schematic in Figure 2 for clarification).
 
Ή
 
Figure 2. Schematic highlighting the manufacturing approach undertaken to develop the
topographically controlled electrospun substrates and summary of chosen biofunctionalization
strategies to modify the electrospun niche-like membranes.
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2.2. Characterization of PCL Electrospun Scaffolds Prior to Biofunctionalization
The electrospun scaffolds were characterized using a scanning electron microscope (SEM).
Samples of 10–12 mm diameter were cut from each mat using a cork borer and they were mounted on
aluminum stubs using double-sided adhesive conductive carbon discs. The samples were sputter-coated
with gold (3 minutes’ total sputtering time) using an Edwards Sputter Coater S150B and viewed in a
Philips XL- 21 SEM with an accelerating voltage of 15 kV. SEM micrographs were used to evaluate the
fiber diameter of the electrospun scaffolds. Six SEM micrographs were selected for samples and fiber
diameters were measured using ImageJ software. In total, 25 fibers were specifically chosen from the
same area in each image by applying a grid for diameter measurement. The values were processed by
calculating the average and standard deviation of the readings.
2.3. Biofunctionalisation of PCL Electrospun Scaffolds
2.3.1. Absorption of Collagen and Heparin
The electrospun membranes were sterilized by immersion in 500 µL of Isopropyl alcohol
(Fisher Scientific, Sheffield, UK) for a minimum of 60 min, removed, and left to dry. Collagen at 50% in
distilled water was prepared from a stock solution of 5 mg/mL in 0.1 M acetic acid and fluorescing
heparin (Thermofisher, Sheffield, UK) at 20% in distilled water was prepared from a stock of 1 mg/mL.
Collagen and heparin were added as a 5 µL drop inside the microfeatures and on plain electrospun
scaffold controls (without synthetic niches) using an Eppendorf precision micro-pipette.
2.3.2. Incorporation of Inorganic Component (Bioactive Glass)
Bioactive glass (BG) was fabricated in house from raw materials matching the specific ratios of
the original 45S5 BG composition introduced by Larry Hench (1998). The glass frit was milled for 1 h
and then, to obtain the desired particle size (<45 µm), the milled BG powder was sieved through a
laboratory stainless steel sieve with an aperture size of 150 µm and 45 µm (Fisher Scientific, Sheffield,
UK). PCL electrospun scaffolds were manufactured using 3 different compositions of glass (0%, 10%,
and 30%). The BG powder was added to the PCL pellets before being dissolved in the solvent and
then stirred at room temperature for 3 h. Afterwards, 3 mL of the prepared solution were spun in each
session according to the previously mentioned parameters (see Section 2.1).
2.4. Materials Characterization after Incorporation of Biofunctional Agents
Sirius red staining was used to identify location of collagen deposits. Samples were stained using
a solution of 0.1% Sirius red in picric acid (Direct Red 80, C.I. 35780, Sigma-Aldrich, Sheffield, UK) for
one hour and washed three times with phosphate buffered saline (PBS; Sigma Aldrich, Sheffield, UK)
to clear the unbounded stain before images were taken. To identify the presence of heparin, a 0.4% (w/v)
Toluidine Blue solution was prepared using 0.1 M sodium acetate buffer (pH = 9). During staining,
samples were incubated for 15 min in 1 mL of staining solution and washed several times before
pictures were taken. Heparin presence was identified by the dark purple staining.
Rheology studies were performed using the different polymer-glass electrospinning solutions;
1 mL of 10% PCL solution from each composition (0%, 10%, and 30% glass of the PCL weight) and
5 mL of the solvent blend were prepared. The samples were then homogenized using a magnetic
stirrer for 3 h before the test. Afterwards, a shear viscosity test was performed using a Physica MCR
301 rotational rheometer with a CP 50-1cone plate, (Anton Paar, Graz, Austria). The viscosity values
were recorded at the lowest measurable shear rate (2 s−1) with a force of 0.61 N, 0.1 mm gap and a
temperature of 25.02 ◦C. A shear rate of 2 s−1 was chosen after a linear pattern indicating constant
viscosity readings was observed in the 2–10 s−1 region (10 s−1 being the termination point). The shear
viscosity of the PCL/BG solution (WU1) was calculated by the ratio of shear stress and corresponding
shear rate as represented by Mezger 2011 [40].
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2.5. Biological Assessment
2.5.1. Cell Culture
Rat MSCs were extracted from rat bone tibia as reported previously [41]. Media was composed
of Dulbecco’s modified Eagle’s medium (DMEM; Sigma Aldrich, Sheffield, UK) supplemented with
10 units/mL penicillin (Sigma Aldrich, Sheffield, UK), 0.1 mg/mL streptomycin (Sigma Aldrich, Sheffield,
UK), 20 Mm L-alanyl glutamine, and 5% Foetal calf serum (FCS) (Biosera, Sheffield, UK), as well as
maintained in a humidified atmosphere of 5% CO2 at 37
◦C. Electrospun samples were transported to
a new set of 24-well plates with 1 mL of fresh culture media per well. In this study, rMSCs were used
up to the 4th passage and prepared in a suspension form. Later, 1 mL of cell suspension containing
50,000 rMSC cells was added to each well. Then, the same number of cells was directly seeded on
wells without any electrospun material (Tissue Culture Plastic) (TCP), to act as positive controls. Cell,
BG, and protein-free controls were also prepared. The plates were incubated at a temperature of 37 ◦C
in 5% CO2 and the cells had media removed and replaced every 3 days.
2.5.2. Cell Viability and Cell Morphology
Metabolic activity for rMSCs was assessed using the PrestoBlue® assay (Life Technologies,
Sheffield, UK) according to the manufacturer’s instructions as an indicator of cell viability and
proliferation at days 1, 7, and 14 of cell culture. Each sample was incubated with 700 µL of 10% (v/v)
PrestoBlue® solution in cell culture media for 1 h and 30 min. After incubation the solution was
transferred to a 96-well plate (200 µL solution per well) and fluorescence was measured using an
Infinite 200 PRO microplate reader at 553/590 nm (Tecan, 2013) and Magellan data analysis software.
Cell morphology was assessed using SEM, fluorescence, and confocal microscopies.
Scanning electron microscopy was performed after 14 days of incubation. rMSCs cultured on
PCL scaffolds were fixed with 4% (v/v) glutaraldehyde solution and washed with PBS and distilled
water. The sample dehydration process was performed by progressively increasing ethanol content
(EtOH) (Sigma Aldrich, Sheffield, UK) in water at concentrations of 25%, 50%, 75%, 90%, and 100% (v/v);
then, dehydrated scaffolds were treated with ethanol:hexamethyldisilazane solution (EtOH:HMDS; 1:1
(v/v); Sigma Aldrich, Sheffield, UK) for 1 h and finally they were treated with 100% (v/v) HMDS solution
for 5 min. Before SEM imaging, HMDS was removed and the samples dried for 1 h at room temperature.
Next, 24 h later, the samples were placed on double-sided carbon discs and fixed on aluminum stamps.
Gold coating was performed using a S150B, Edwards sputter for 3 min before being scanned, and SEM
micrographs were obtained by Philips XL 20 electron microscope. For the fluorescence study, cells were
stained with 4′, 6-diamidino-2-phenylindole (DAPI; nuclei) and conjugated fluorescein isothiocyanate
(FITC; actin fibers). After washing with PBS, cells were fixed with 4% (v/v) paraformaldehyde for 1 h.
Prior to labelling, a solution of 0.1% (v/v) Triton-X was added to each sample for 20 min to permeabilize
cell membranes and facilitate the staining process. Then, 10 mL of PBS solution with 0.1% (v/v) DAPI
and 0.2% (v/v) FITC were added for 40 min at room temperature. Images were obtained using a
fluorescence microscope (Axioplan 2, ZEISS) and a laser scanning microscope S10 META.
2.5.3. Alkaline Phosphatase Assay (ALP)
ALP, a marker of early osteogenic differentiation, can provide an indication of pre-osteoblastic
activity. To measure ALP activity, a substrate solution was prepared by dissolving one tablet of
5-Bromo-4-chloro-3-indolyl phosphate/Nitro blue tetrazolium (BCIP-NBT, Sigma Aldrich, Sheffield,
UK) in 10 mL of distilled water. rMSCs cultured scaffolds were washed with PBS, fixed with 4% (v/v)
formaldehyde solution at room temperature for 60 s, and washed with 0.05% (v/v) Tween 20 in a PBS
buffer solution. Afterwards, 250 µL of substrate solution were added to cover the scaffold and samples
were incubated for 5–10 min. After washing with the buffer solution, samples were kept in PBS until
image analysis by optical microscope (SteREO Discovery V8 microscopy). ALP was measured by
calculating the percentage of the image which contained the ALP stain. Images were analyzed using
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ImageJ. Images underwent color threshold, set to 8 bit images, and then the threshold tool was used to
set a binary color system. The entire image was then measured using “the area measure tool” to get a
percentage of the ALP stain. In total, 3 images for each condition were analyzed.
2.6. Statistical Analysis
All the data is presented as a mean± standard deviation. Data was analyzed using GraphPad Prism
7. T test (t-Test: two-sample assuming equal variances) and one-way ANOVA were used for parameter
estimation and hypothesis testing, with p < 0.05 and p < 0.01 considered to be statistically significant.
3. Results
3.1. Electrospun Scaffold’s Shape, Thickness, and Fiber Morphology
The thickness of scaffolds was measured using a digital micrometer. Scaffold thickness showed
a variation between 0.1 to 0.2 mm. The diameter of the circular-cut scaffolds was also measured
and ranged between 1.3 to 1.5 cm. Figure 3a,b shows low magnification images of the plain and
scaffolds with niches. Both scaffolds were observed to have a 3D structure with interconnected voids
and randomly oriented fibers. At a very high magnification, the fiber morphology appeared to be
homogenous and clearly formed a uniform 3D surface (Figure 3c). The synthetic model of a niche
appeared to be a confined cavity with a higher edge than the surrounding environment. At the edge
of the niche fibers were of lower density and were more aligned (Figure 3d,e). SEM pictures for
samples with PCL/BG glass compositions (10% and 30% BG) showed regions of increased diameter
and irregular shape confirming the BG particles where present within the mat (Figure 3f–h).
The morphology of the niche-like structures was also characterized using SEM (Figure 4a).
Areas with different fiber alignments were identified within the synthetic niches (Figure 4b–d),
which were characterized using ImageJ. Significant differences in alignment were found between
the fibers forming the niche walls and the fibers in the top and bottom of the niche (Figure 4e);
these differences in alignment resulted in changes in cell morphology (see SEM colored images
in Figure 4f,g) with rMSCs presenting a more elongated phenotype when growing on the aligned
niche walls.
3.2. Rheological Properties for Bioglass-Doped Electrospinning Solutions
Rheology tests were repeated three times for each composition under the same conditions and
the viscosity values at a specific shear rate (2 s−1) were selected for analysis. The mean and standard
deviation values were calculated for each of the solution readings, and then the average viscosity
values were plotted against different BG compositions of PCL/BG solution as presented in Figure 5e.
The inclusion of BG particles at different proportions significantly increased (p = 0.0484) the solution
viscosity (under the same environmental conditions). No significant differences in fiber morphology
were observed under SEM (Figure 5a–c) and no significant differences in fiber diameter (p= 0.3747) were
found when comparing electrospun membranes manufactured with the different BG concentrations
(Figure 5d,f).
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Figure 3. Scanning electron micrographs of the electrospun scaffolds: (a) Scanning electron microscopy
(SEM) of Polycaprolactone (PCL) electrospun mesh, plain sample; (b) SEM of PCL electrospun
niche sample showing the complete niche structure with the surrounding plain area between niches;
(c) PCL electrospun fibers randomly distributed in a plain scaffold; (d) SEM picture showing the
different patterns of fiber distribution within the niche structure; (e) SEM micrographs of BG powder,
showing milled BG particles with irregular coarse surfaces and variable particle sizes within the same
sample; (f) electrospun plain sample with BG, arrow points at BG particles appear within the structure
of the randomly oriented fibers; (g) electrospun niche samples with BG, circle shows the edge of the
niche; (h) higher magnification of the electrospun niche samples of PCL with BG, arrow points at BG
particles appear within the structure of the aligned fibers.
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Figure 4. SEM analysis of electrospun scaffolds fibers and alignment impact on cell morphology:
(a) SEM micrograph of synthetic niche in electrospun scaffold; (b–d) SEM images showing different
sections of fibers within the niche, specifically: (b) Randomly aligned fiber area outside niche; (c) aligned
fibers in the niche wall; (d) randomly aligned fiber area at the bottom of the niche; (e) analysis of the
fiber alignment within the different sections of the niche presented as a histogram; (f) morphology of
rMSCs growing on more random fibers; (g) morphology of rMSCs growing on more aligned fibers.
 
Figure 5. SEM micrographs of PCL/BG plain samples showing the effect of BG concentration on
fiber morphology and diameter measurements: (a) PCL/0% BG; (b) PCL/10% BG; (c) PCL/30% BG;
(d) analysis of fiber diameter from electrospun scaffolds by use of a histogram showing size distribution;
(e) bar graph showing the effect of the BG concentrations on the average viscosity of the PCL/BG
solutions; (f) bar graph showing the effect of BG concentrations on the fiber diameter.
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3.3. Incorporation of Biomolecules on the PCL Scaffolds
The membranes were successfully coated by collagen and heparin. Figure 6c shows the scaffolds
with niches stained positively for collagen (after washing the unbounded stain). The chosen fluorescing
heparin can be easily detected throughout the experiment (Figure 7c,d,h). Interestingly, collagen and
heparin demonstrated different interaction with the scaffold material. When collagen was added inside
the niche, it completely covered the niche and formed a patch like structure (Figure 6b), unlike the
heparin which only covered the individual fibers and the niche was still identifiable (Figure 7b).
 
Figure 6. Deposition of collagen onto electrospun scaffolds and 14th day culture with MSCs: (a) SEM
image of plain scaffolds with collagen deposited on the surface. Collagen false colored blue using
photoshop; (b) SEM image of collagen deposited into niches on electrospun scaffolds. Collagen false
colored blue; (c) Sirius red staining of scaffold control and red staining of scaffolds with collagen
deposition showing the presence of collagen; (d) cell metabolic data from PrestoBlue® assay based
on a 14 day culture of rMSC cells on electrospun scaffolds with and without niches and collagen.
No statistical difference is found between any of the conditions, ANOVA; (e) fluorescence image
of nuclei DAPI staining (blue) 14 days culture of rMSC cells on plain scaffolds without collagen;
(f) fluorescence image of nuclei DAPI staining (blue) from 14 days culture of rMSC cells on plain
scaffolds with collagen (false colored pink).
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Figure 7. Deposition of heparin onto electrospun scaffolds and 14 day culture with rMSCs: (a) SEM
image of plain scaffolds with heparin deposited on the surface; (b) SEM image of heparin deposited
into niches; (c) fluorescent image of fluorescent heparin (green) deposited onto electrospun scaffolds
without niches; (d) fluorescent image of fluorescent heparin (green) deposited onto electrospun scaffold
with niches; (e) toluidine Blue staining for plain heparin coated scaffolds and control; (f) cell metabolic
data from PrestoBlue® assay based on a 14 day culture of rMSC cells on electrospun scaffolds with
and without niches and heparin. No statistical difference is found between any of the conditions,
ANOVA test used, bars are the mean ± SD (N = 1, n = 3); (g) fluorescent image of nuclei DAPI
staining (blue) 14 days culture of rMSC cells on plain scaffold without heparin; (h) fluorescent image
of nuclei DAPI staining (blue) and fluorescent heparin (green) from 14 days culture of rMSC cells on
plain scaffold.
3.4. Cells Viability on Biofunctionalized PCL Scaffolds
Deposition of collagen on electrospun scaffolds was corroborated using SEM and Sirius red
staining (Figure 6a–c). On the other hand, deposition of heparin was demonstrated using SEM and
toluidine blue staining (Figure 7a,b,e) as well as fluorescence microscopy (Figure 7c,d). PrestoBlue®
assays showed that rMSCs were metabolic active and able to proliferate when cultured on all the
Processes 2020, 8, 1341 12 of 19
studied scaffolds (Figure 6d,f). Overall, the presence or absence of biomolecules (collagen or heparin),
as well as the presence or absence of the synthetic niches, did not show any evidence of stimulating or
suppressing cells metabolic activity. When observing cell adhesion on different substrates, electrospun
scaffolds that were not treated with collagen or heparin displayed a lower number of cells attached
but with similar metabolic activity. On heparin and collagen treated samples, cells seemed to adhere
and spread better along the fibers which resulted in higher cell density areas for the protein-treated
samples (when compared to non-treated PCL samples) (Figure 6e,f).
3.5. Cells Viability on Bioglass Doped Scaffolds
Results confirmed that plain and microfabricated samples doped with BG showed no differences
in metabolic activity from days 1–14 (Figure 9h). Similar to the protein coated scaffolds, statistical
analysis showed that no design or composition was significantly different than the others. The images
obtained by fluorescence, scanning, and confocal microscopies showed cells attached to the matrices
with and without niches for all the studied BG concentrations (Figure 8a–g). Plain samples showed
that cells were uniformly distributed across the sample surfaces indicating a comparable cell-substrate
interaction for all the compositions. The niche structure seemed to favor deeper cell infiltration (up to
180 µm as highlighted in the heat map shown in Figure 8h) and cells followed the alignment of fibers
at the wall of the niche.
 
ΐ
ΐ
Figure 8. Cell morphology and distribution on scaffolds functionalized with BG: (a) fluorescent
microscopy of nuclei DAPI staining (blue) of plain samples with 10% BG; (b) fluorescent microscopy of
image of nuclei DAPI staining (blue) of niche samples with 10% BG; (c) SEM micrographs of 30% BG
plain samples; (d) SEM micrographs of niche samples with 10% BG; (e) confocal microscopy of niche
10% BG; (f) confocal microscopy of niche bottom 30% BG; (g) Confocal microscopy of plain 10% BG;
(h) heat map of confocal imaging microscopy for niche structure, each color indicates a specific depth
of cell penetration. Cells appear to penetrate as deep as 180 µm at the center of the niche (red area),
while around the niche edge they exhibit superficial expansion (blue area).
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3.6. Osteogenic Properties of Bioactive Glass
The results from the differential ALP studies are presented in Figure 9. Optical microscopy images
allowed us to easily compare the osteogenic behavior of rMSCs seeded on scaffolds with different
PCL/BG compositions. As expected, no osteogenic activity was noticed on the cell-free samples.
Similarly, cells seeded on scaffolds containing 0% BG exhibited lower osteogenic activity for both niche
and plain scaffolds (Figure 9a,b). Higher levels of ALP were produced by cells seeded on samples
incorporating 10% and 30% BG (Figure 9c–f) and for samples incorporating niche-like structures
(Figure 9g). Plain samples showed a patchy distribution for the ALP stained areas (Figure 9a,c,e).
Interestingly, for the niche samples, ALP activity was more noticeable towards the walls of the niche
(where the fibers are aligned; see Figure 9d for a high magnification view) rather than towards the
center of the niches (with randomly distributed fibers) (Figure 9d,f).
 
h)
 
Figure 9. Biological evaluation of scaffolds functionalized with BG. ALP assay pictures: (a) plain
sample 0% BG; (b) niche sample 0% BG; (c) plain sample 10% BG; (d) Niche sample 10% BG; (e) plain
30% BG; (f) niche sample 30% BG; (g) ALP quantification for niche samples obtained by calculating
the percentage of stain coverage in the optical images; (h) cell metabolic data from PrestoBlue® assay
based on comparing the effect of membrane design and composition between day 1 and day 14 of
the experiment.
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4. Discussion
The scientific community has recently shown a growing interest in mimicking the physiological
environment in which adult stem cells naturally reside, since this environment has been reported
to have a direct effect in controlling cell behavior and fate [13,19]. Electrospinning strategies have
been broadly used for the production of fibrous matrices that can mimic, to an extent, the natural
structure of the extracellular matrix [42–44]. The versatility of the electrospinning technique enables
the incorporation of intricate hierarchical features within the electrospun membranes, for example,
by introducing additive manufacturing techniques within the fabrication process [45]. Previous work
developed by our group reported the ability of creating complex electrospun microenvironments
using different combinations of fabrication techniques, which included selective laser melting [15],
extrusion or robocasting [46], stereolithography [22], and 2 photon polymerization [21]; however,
these studies have primarily focused on enhancing scaffold physical features and on optimizing the
artificial niche morphology and the construct design. This work reports a step further in the area of stem
cell niche biofabrication by presenting a palette of biofunctionalization approaches that intend to add
an extra degree of hierarchy to our models. As previously described, the niche entity comprises both
physical and chemical cues. The models we present here target both of these key aspects. In essence,
the complex design of our previously developed microstructured membranes has now been improved
via the incorporation of biofunctional additives with the final aim of developing more physiologically
relevant artificial stem cell microenvironments for bone tissue engineering.
The development of “synthetic stem cell niches” is a possibility yet to be fully explored in bone
regeneration research. For mimicking the physiological stem cell niche, it is necessary to have a wide
understanding of its structure and composition. The development of topographically controlled bone
regeneration platforms is challenging since the bone structure is not easy to recapitulate. On the one
hand, there is not a single “bone stem cell niche as such” but a combination of physical [47] and
chemical [48] factors that can drive cells towards an osteogenic pathway.
Although topographically-controlled electrospun membranes have demonstrated to be good
models for studying cell behavior, they have sometimes shown to be a simplistic approach for studying
bone healing. Therefore, this work aimed to demonstrate the versatility and functionalization potential
offered by topographically modified electrospun arrays via the use of relevant proteins and ceramic
materials. For this purpose, we selected key components of the stem cell niche (collagen, GAGs,
and inorganic components).
GAGs of the heparin/heparan sulphate (HS) class and key components of ECM are of particular
interest for their roles during bone remodeling, particularly their ability to bind, stabilize, and protect
growth factors from degradation. GAG structural variation seems to be tissue-dependent and,
as previously reported, heparin/HS can selectively interact with BMP-2, increasing its tissue availability
in the local area and enhancing bone healing [49]. Other studies have described how GAGs stimulate
the osteogenic differentiation by upregulating the expression of osteogenic genes [50] and how different
sulfation patterns and length can influence heparin selectivity to BMP-2. Collagen is another ECM
component majorly present in bone tissue in the form of collagen type I. At nanoscopic level, bone tissue
is composed of triple helical collagen molecules that group into collagen fibrils. HA crystals are
embedded between collagen gaps increasing structure rigidity [51]. Collagen acts as a template for
mineralization initiation and propagation [52]. BG has been confirmed to stimulate enzyme activity [53],
vascularization [54], osteoblast adhesion, and differentiation. It can also stimulate mesenchymal cell
differentiation into osteoblasts [55]. A significant finding reported by Xynos et al. is that 45S5 BG is
able to increase the expression of genes that govern osteogenesis and growth factor production [56].
In this study, our microfabricated patterns were developed using electrospinning, which is broadly
used in tissue engineering for developing fibrous mats. Although electrospinning is versatile and
generally a robust technique, the inclusion of ceramic materials within manufacturing can result
challenging due to changes in viscosity. The polymeric solution viscosity depends on the polymer
concentration and the presence and proportion of additives which in turn can affect fiber diameter
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and morphology during manufacturing. Hence, a rotational shear rheology study was performed
to identify the effect of glass particles incorporation on the solution’s viscosity. Our results and
statistical analysis confirmed these observations showing significantly higher viscosity for solutions
with 30% BG compared to BG-free samples (Figure 5d). Similar results were reported by Fujihara et al.,
with PCL/CaCO3 composite nanofibres [57] and Kouhi et al., with PCL/nBG composite nanofibers [58].
In addition, it has been speculated that higher concentrations of BG will increase the charge density
on the electrospinning jet surface leading to higher electrostatic force and smaller fiber diameter [59].
In our case, an increased solution viscosity in combination with higher charge density might explain
why there were no significant changes in fiber diameter for different BG concentrations.
All of the proposed samples were seeded with rMSCs and tested for their biocompatibility using
a PrestoBlue® assay to evaluate the cellular metabolic activity. Cells proliferated on both collagen and
heparin-treated scaffolds, as well as TCP, at the same rate, using the same conditions with no significant
differences. Although PrestoBlue® tests showed no difference in the cellular activity between the
scaffolds with and without proteins, the fluorescent images showed a greater number of cells when
the scaffolds were functionalized with proteins. We hypothesized that this could have been due to
the differentiation of cells to osteoblasts (normally between day 7 and 14), where cells show low
metabolic activity as reported by Huang et al. [60]. Further experiments would need to be developed
to corroborate this hypothesis.
We also identified that the density of the cell distribution was directly related to the position of
the protein (Figures 6f and 7h). rMSCs implied clustering and migration in the range of the protein
drop; meanwhile, almost no cellular clusters appeared in the area between the drops. Shi et al.
detected similar observations for NIH3T3 cells by incorporating fibronectin gradients into electrospun
mats. Further, the study reported a difference in the cellular morphology in relation with the protein
concentration [61]. The fluorescent images confirmed the presence of cells inside the niche area and
at its edge. We further investigated this by confocal microscopy and we found out that cells were
not only growing on the surface, but also penetrated deeply in the inner layers of the scaffolds and
particularly inside the niche area. Our current data suggests that the higher surface area offered by the
micropocket might have a positive effect on encouraging cell growth, however, further quantification
of cell densities inside and outside the microstructures would be needed to elucidate this claim.
It has been stated that high levels of Na2O (BG dissolution product) can elevate the local pH
value and inhibit cell growth [62]. Therefore, this study investigated the cytotoxic potential of PCL/BG
ratios as high as 30 wt.%. Results suggest that none of the tested compositions had a detrimental
effect on cell metabolic activity. After 14 days of culturing, all seeded samples showed comparable
metabolic activity to the TCP controls, indicating that all PCL/BG compositions supported normal cell
growth. Therefore, there was no significant difference between the proposed designs. This could be
attributed to the high compatibility of PCL and the uniform distribution of the BG particles within
the electrospun material. Coincident findings were reported by Fabbri et al. for PCL/BG scaffolds
fabricated by solid liquid phase separation [63].
ALP assay was performed to estimate the potential osteoblastic differentiation of rMSCs on
BG-treated membranes; BG had been reported to have an osteogenic effect on rMSCs, compared to pure
PCL mats [59,64]. Our study suggested that both the intricate design and BG concentration influenced
the rMSCs osteogenic activity and we reported that niche samples with 30% BG showed an increased
level of ALP production around the wall niche area (with higher fiber alignment), unlike the plain
samples of the same composition (see high magnification images in Figure 9c,d).
This study considers the role of the scaffold design and bio-active molecules in assisting stem
cells differentiation into osteoblasts, which is a key factor in the field of bone tissue engineering.
We have successfully employed electrospinning and physical adsorption strategies to immobilize the
bioactive molecules on the surface of PCL nanofibers. However, physical surface adsorption depends
on electrostatic and intermolecular interactions, which are not particularly strong and might not be
sufficient for ensuring long term stabilization [65]. Meanwhile, for the development of bone tissue
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engineering models, chemical immobilization might offer a more stable covalent attachment to the
nanofiber [66]. Our group is currently exploring strategies for comparing our current findings to
biofunctional agents immobilized using chemical crosslinking to the PCL nanofibers, for example,
via the use of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccimide
(NHS) and via the use of click chemistry approaches to help to inhibit PCL degradation and increase
model stability.
Our novel fibrous scaffolds open the door for the development of new and physiologically relevant
micro-fabricated membranes that can be used for studying stem cell behavior, as well as for the
fabrication of future medical devices for bone tissue repair.
5. Conclusions
The aim of this research was to fabricate a multi-functional micro-fabricated scaffold using
key mechano-biological components found in the native bone microenvironment. The presented
research also aimed to evaluate the potential of this scaffold to be used as bone tissue engineering
model and, ultimately, the basis for a therapeutic device. Our results demonstrated the feasibility of
manufacturing electrospun platforms that combined topographical features and biofunctionalization
cues. Cell responses to these innovative membranes were also analyzed using relevant primary MSCs.
In vitro studies showed that all the materials were biocompatible, emphasizing the protective function
of the niche environment (particularly in the presence of biofunctiontal agents), supporting normal cell
expansion, migration, and differentiation. It was concluded that stem cell niche biofabrication offers a
new strategy for enhancing scaffold functionality in new tissue engineering models and devices.
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